Advertisement

NeuBase Therapeutics, Inc. NBSE

Set alert

Price alert · NBSE

All alert types
0.38 +0.38 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
1.42M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-0.03
Beta
0.94
Short ratio
0.24
Inst. own
11.87%
Dividend
0.00
Ex-div date
Earnings
Dec 26, 2024
50-d avg
0.472587
200-d avg
0.722122
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NBSE has not been loaded yet. Try again in a moment.

Revenue & Expenses

Net Loss → Expenses: $1.63MExpenses → Gross Loss: $307.00KExpenses → Selling, General & Admin: $867.00KExpenses → Research & Development: $451.00KRevenue → Cost of Revenue: $130.00KNet Loss$1.63MCost of Revenue$437.00KExpenses$1.63MGross Loss$307.00KSelling, General & Admin$867.00KResearch & Development$451.00KRevenue$130.00K

Period ending Sep 30, 2023 · select a line to chart its history

Income statement

NBSE quarterly income statement
2.81M
387.56K
1.20M
-2.81M
122
-1.82M
-1.82M
-1.82M
-1.82M
-0.66
-0.66
-0.66
-1.82M
-1.82M
2.76M
2.76M

Balance sheet

NBSE quarterly balance sheet
12.57M
12.57M
13.35M
5.14M
18.62M
500.82K
5.34M
4.65M
4.83M
9.48M
-116.47M
9.14M
9.14M
5.27M
5.34M
4.83M
258.64K

Cash flow

NBSE quarterly cash flow
250.25K
-174.50K
-2.18M
-154.39K
-20.11K
-2.00M
-292.34K
Advertisement